Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pregabalin in Behavioral and Psychological Symptoms of Dementia (BPSD)
IRCT20201201049553N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pregabalin in Dementia, sponsored by Tehran University of Medical Sciences. Started Jul 2021; status: completed.
02
Drugs
pregabalin
03
Conditions
Dementia
Beyond the preview
Go deeper on IRCT20201201049553N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201201049553N1.